Key Highlights

  • Lifeway Foods (NASDAQ:LWAY) fell 4.3% in after-hours trading on November 12, 2026 after reporting third-quarter results.
  • Net sales hit a record USD 67.8 million, up 18.6%, but gross Margin dropped to 18.0% from 28.7% on elevated input and transportation costs.
  • Net income fell to USD 0.3 million, or USD 0.02 per share, from USD 3.5 million, or USD 0.23, a year earlier.
  • Management said it is on pace for record 2026 sales and expects price increases and a Facility scale-up to restore margins in 2027.

Volume Up, Profit Down

The report from Lifeway Foods (NASDAQ:LWAY) shows a company selling more of its product while earning much less on each unit. Net sales of USD 67.8 million rose 18.6% on higher volumes of drinkable kefir, and nine-month sales of USD 197.7 million were up 25.8%. The kefir category leader describes the quarter as another record. The profit lines tell a different story. Gross margin fell to 18.0% from 28.7%, Operating Income dropped to USD 1.085 million from USD 5.040 million and Net Income fell to USD 0.3 million, or USD 0.02 per share, below the estimate. Management blamed an elevated input cost environment, including higher transportation costs, and said the pressure is expected to persist into the fourth quarter. Selling and administrative costs eased to 16.2% of sales from 19.6%, which cushioned the operating line, but not enough to offset the fall in gross profit. The 4.3% decline after hours is modest given the size of the Earnings miss.

Capacity Investment and Cash

Growth has required heavy spending. Nine-month Capital Expenditure reached USD 22.8 million, up from USD 9.7 million, as the company scales production capacity, and the Waukesha facility scale-up is due to finish in early 2027. Operating Cash Flow for the nine months fell to USD 4.9 million from USD 10.7 million. Funding came partly from debt, with a line of Credit of USD 11.95 million and a note payable of USD 12.0 million added since the end of 2025, while cash rose to USD 6.975 million. The capacity investment explains why the company can grow Volume at double-digit rates, and it also explains why Leverage and interest costs now matter more to the earnings picture. If input costs stay high, the new plant could weigh on returns for longer than planned, so the timing of margin recovery is the key variable for the investment case.

Pricing Power Will Decide the Outcome

Management plans price increases that roll out through the end of the year and into the first quarter of 2027, and says its 2027 outlook is unchanged, with expected gross margin expansion and better profitability. The success of that plan depends on whether consumers accept higher prices in a category where private label and rival brands compete for shelf space. Kefir has benefited from Demand for gut health and high-protein foods, and Lifeway holds category leadership, which supports pricing power. Risks include milk cost volatility, freight costs, retailer pushback and delays in the new facility. Investors in Lifeway Foods (NASDAQ:LWAY) will watch fourth-quarter gross margin, pricing realised on shelf, Debt levels and the timing of plant completion. Sales growth is not the concern. The question is how quickly the margin returns toward the high-twenties, which would restore earnings to levels seen last year.

Where Things Stand

Lifeway Foods fell 4.3% after hours after reporting record third-quarter sales of USD 67.8 million but a drop in gross margin to 18.0% and net income of USD 0.02 per share. Price increases through early 2027 and a new facility are meant to restore profit. Input cost relief, debt costs and customer acceptance of higher prices will decide how fast that happens.